RESUMEN
Most clinical gait laboratories use the conventional gait analysis model. This model uses a computational method called Direct Kinematics (DK) to calculate joint kinematics. In contrast, musculoskeletal modelling approaches use Inverse Kinematics (IK) to obtain joint angles. IK allows additional analysis (e.g. muscle-tendon length estimates), which may provide valuable information for clinical decision-making in people with movement disorders. The twofold aims of the current study were: (1) to compare joint kinematics obtained by a clinical DK model (Vicon Plug-in-Gait) with those produced by a widely used IK model (available with the OpenSim distribution), and (2) to evaluate the difference in joint kinematics that can be solely attributed to the different computational methods (DK versus IK), anatomical models and marker sets by using MRI based models. Eight children with cerebral palsy were recruited and presented for gait and MRI data collection sessions. Differences in joint kinematics up to 13° were found between the Plug-in-Gait and the gait 2392 OpenSim model. The majority of these differences (94.4%) were attributed to differences in the anatomical models, which included different anatomical segment frames and joint constraints. Different computational methods (DK versus IK) were responsible for only 2.7% of the differences. We recommend using the same anatomical model for kinematic and musculoskeletal analysis to ensure consistency between the obtained joint angles and musculoskeletal estimates.
Asunto(s)
Parálisis Cerebral/fisiopatología , Marcha/fisiología , Articulaciones/fisiopatología , Modelos Biológicos , Adolescente , Fenómenos Biomecánicos , Parálisis Cerebral/diagnóstico por imagen , Niño , Preescolar , Femenino , Humanos , Articulaciones/diagnóstico por imagen , Imagen por Resonancia Magnética , MasculinoRESUMEN
We present the first reported case of a combined medial humeral condyle fracture with ipsilateral radial head dislocation. This injury was sustained by a 7-year-old girl following a fall on an outstretched hand. The operative technique is described. At 6-month follow-up, the patient had normal alignment of the limb and achieved full range of motion.
Asunto(s)
Fracturas del Húmero/etiología , Luxaciones Articulares/etiología , Radio (Anatomía)/lesiones , Accidentes por Caídas , Niño , Femenino , Humanos , Fracturas del Húmero/diagnóstico por imagen , Luxaciones Articulares/diagnóstico por imagen , Radiografía , Radio (Anatomía)/diagnóstico por imagenRESUMEN
BACKGROUND: The controlled evidence favoring botulinum toxin A (BtA) treatment for spasticity in cerebral palsy is based on short-term studies. METHODS: We conducted a randomized, double-blind, placebo-controlled, parallel-group study of BtA (Dysport) for leg spasticity in 64 children with cerebral palsy. For 2 years, the children received trial injections of up to 30 mu/kg every 3 months if clinically indicated. RESULTS: For the primary endpoints of Gross Motor Function Measure (GMFM) and Pediatric Evaluation of Disability Index (PEDI) scaled scores at 2 years (trough rather than peak effect), there were no differences between the mean change scores of each group. For the GMFM total score, the 95% CI of -4.81 to 1.90 excluded a 5-point difference in either direction, and a 2-point benefit with 95% confidence. There were no differences in adverse events. CONCLUSIONS: There was no evidence of cumulative or persisting benefit from repeated botulinum toxin A (BtA) at the injection cycle troughs at 1 year or 2 years. The dose was not enough to change spasticity measures and thus GMFM in this heterogeneous group. Ceiling effects in GMFM and Pediatric Evaluation of Disability Index (PEDI) may have reduced responsiveness. This finding does not deny the value, individually, of single injection cycles or prove that repeating them is unhelpful. In this regard, BtA treatment can be viewed in the same light as other temporary measures to relieve spasticity, such as oral or intrathecal agents: there is no evidence of continuing benefit if the treatment ceases. The study provides long-term, fully controlled adverse event data and has not revealed any long-term adverse effects.
Asunto(s)
Toxinas Botulínicas Tipo A/uso terapéutico , Parálisis Cerebral/tratamiento farmacológico , Espasticidad Muscular/prevención & control , Fármacos Neuromusculares/uso terapéutico , Artrometría Articular , Parálisis Cerebral/complicaciones , Preescolar , Método Doble Ciego , Femenino , Humanos , Inyecciones , Masculino , Espasticidad Muscular/etiología , Resultado del TratamientoRESUMEN
Tarsal coalition refers to a union of two or more tarsal bones. The union may be fibrous, cartilaginous, or bony. The most common sites of tarsal coalition reported in the literature are the calcaneonavicular, the talocalcaneal, and, less commonly, the talonavicular areas. Bilateral coexistent multiple tarsal coalitions are a rare occurrence. The authors present a case report of a 17-year-old boy with bilateral coexistent calcaneonavicular and talonavicular bars. The diagnosis was established by radiographs and CT scanning. The patient was treated conservatively with immobilization of the foot in a below-knee walking plaster cast followed by the use of an orthosis with a lateral iron and a medial T strap. The patient was pain-free at 2-year follow-up.